Dr. Robert Anthony Kahns is a pharmacist who is specialized in Pharmacotherapy in Tacoma, Washington. Patients can reach him at 9601 Steilacoom Blvd Sw, Bld 13, Tacoma or contact him on 253-756-2521. Active license number of Dr. Robert Anthony Kahns is PH00064237 for Pharmacotherapy in Washington. Dr. Robert Anthony Kahns is a licensed pharmacist who has demonstrated specialized knowledge and skill in optimizing pharmacotherapeutic care of patients, by developing, implementing, monitoring, and modifying complex treatment plans, providing advanced level education and consultation, and collaborating with other health professionals in the management of therapy.
Complete Profile:
Dr. Robert Anthony Kahns speciality, credentials, practice address, contact phone number and fax are as below. Patients can call on the below given phone number for enquiries.
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details of Dr. Robert Anthony Kahns are as mentioned below.
NPI Number:
1275549719
NPI Enumeration Date:
01 Aug, 2006
NPI Last Update On:
08 Jul, 2007
Medical Licenses:
Pharmacists can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Dr. Robert Anthony Kahns are as mentioned below.
Specialization
License Number
State
Status
Pharmacotherapy
PH00064237
Washington
Primary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
6764 67th Ln Se, Auburn, Washington
Zip:
98092-8204
Phone Number:
253-333-6469
Fax Number:
--
Patients can reach Dr. Robert Anthony Kahns at 9601 Steilacoom Blvd Sw, Bld 13, Tacoma, Washington or can call on phone at 253-756-2521.
Comments/ Reviews:
*Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 November, 2024.